1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Narcolepsy: Opportunity Analysis and Forecasts to 2027

Narcolepsy: Opportunity Analysis and Forecasts to 2027

  • June 2018
  • 103 pages
  • ID: 5500190
  • Format: PDF
  • By GlobalData

Summary

Table of Contents

Search Inside

Narcolepsy: Opportunity Analysis and Forecasts to 2027

Summary
Drug sales for Narcolepsy in 2017 were approximately $1.39B across the seven major markets(US, France, Germany, Italy, Spain, UK, and Japan). Over the 10-year forecast period, the market is expected to grow to $3.7B at a CAGR of 10.4%. This growth will be driven by the launch of five late-stage pipeline products. The two highest selling drugs are expected to be Avadel’s/ Sodium oxybate ER and Jazz Pharmaceutical’s/JZP-258, which both address some of the unmet needs in the market.

Narcolepsy is a chronic sleep disorder characterized by two major symptoms, excessive daytime sleepiness (EDS) and cataplexy.There are two forms of narcolepsy recognized by The International Classification of Sleep Disorders: narcolepsy with cataplexy, also called narcolepsy type 1 (NT1); and narcolepsy without cataplexy, known as narcolepsy type 2 (NT2).

NT1 is most commonly caused by a deficiency of central nervous system (CNS) hypocretin (hcrt also called orexin) in the hypothalamus, while the cause for NT2 is still unknown and patients usually present normal levels of orexin.

There are currently few approved therapies available for narcolepsy; the majority of drugs are used off-label.Treatment needs to be tailored to the type of narcolepsy, NT1 or NT2.

Current treatments centre on the management of sleepiness and cataplexy symptoms, modafinils remaining the standard of care in the treatment of sleepiness while sodium oxybate for cataplexy symptoms. These therapies provide the best relief of symptoms, with Provigil (modafinil) and Xyrem (sodium oxybate) being the two most popular branded drugs.

The report "Narcolepsy: Opportunity Analysis and Forecasts to 2027", provides detailed insights into the market dynamics of this highly competitive space. This analysis also includes the evaluation of the commercial and clinical profiles of pipeline drugs, and their sales forecasts for the narcolepsy indication over the 2017-2027 periods.

The report specifically helps in answering -
- What are the key Narcolepsy treatments in 2017?
- When will the late stage pipeline products launch, and how will it affect drug sales and the overall Narcolepsy market in the 7MM?
- Which unmet needs will remain unaddressed in the forecast period and what opportunities remain for pharmaceutical companies?

Companies mentioned: Teva, Jazz Pharmaceuticals, Bioproject SCR, Avadel Pharmaceuticals, GSK, Pfizer, Theranexus, Flamel Ireland, NLS Pharma, Taisho Pharmaceutical, Balance Therapeutics.

Scope
- Overview of Narcolepsy, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized Narcolepsy therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in two patient segments (Type 1 and Type 2) forecast from 2017 to 2027.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the Narcolepsy therapeutics market
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for Narcolepsy therapy. The most promising candidates in Phase III development are profiled.
- Analysis of the current and future market competition in the global Narcolepsy therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Narcolepsy therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Narcolepsy therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
30% Off

($10995)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Pruritus - Pipeline Review, H2 2019

Pruritus - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Pruritus - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline Review, H2 2019, provides an overview of the Pruritus (Dermatology) pipeline ...

Contact Dermatitis - Pipeline Review, H2 2019

Contact Dermatitis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Contact Dermatitis - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Contact Dermatitis - Pipeline Review, H2 2019, provides an overview of the Contact Dermatitis ...

West Nile Virus Infections - Pipeline Review, H2 2019

West Nile Virus Infections - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

West Nile Virus Infections - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide West Nile Virus Infections - Pipeline Review, H2 2019, provides an overview of ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on